Triple Negative Breast Neoplasms
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
The expression of miR-92b had a negative correlation with the expression of Gabra3 in TNBC tissues.
|
31841197 |
2019 |
Triple-Negative Breast Carcinoma
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
The expression of miR-92b had a negative correlation with the expression of Gabra3 in TNBC tissues.
|
31841197 |
2019 |
Epilepsy
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
In summary, our results reveal that rare loss-of-function variants in GABRA3 increase the risk for a varying combination of epilepsy, intellectual disability/developmental delay and dysmorphic features, presenting in some pedigrees with an X-linked inheritance pattern.
|
29053855 |
2017 |
Encephalopathies
|
0.010 |
GeneticVariation
|
group |
BEFREE |
Rare GABRA3 variants are associated with epileptic seizures, encephalopathy and dysmorphic features.
|
29053855 |
2017 |
Tumor Progression
|
0.010 |
Biomarker
|
phenotype |
BEFREE |
Our previous study demonstrated that Gabra3 plays critical roles in cancer progression.
|
29078789 |
2017 |
Pancreatic carcinoma
|
0.010 |
Biomarker
|
disease |
BEFREE |
However, whether Gabra3 is regulated by miRNAs in PC remains unknown.
|
29078789 |
2017 |
Malignant neoplasm of pancreas
|
0.010 |
Biomarker
|
disease |
BEFREE |
However, whether Gabra3 is regulated by miRNAs in PC remains unknown.
|
29078789 |
2017 |
Dysmorphic features
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
In summary, our results reveal that rare loss-of-function variants in GABRA3 increase the risk for a varying combination of epilepsy, intellectual disability/developmental delay and dysmorphic features, presenting in some pedigrees with an X-linked inheritance pattern.
|
29053855 |
2017 |
Epileptic Seizures
|
0.010 |
GeneticVariation
|
phenotype |
BEFREE |
Rare GABRA3 variants are associated with epileptic seizures, encephalopathy and dysmorphic features.
|
29053855 |
2017 |
Malignant neoplasm of breast
|
0.010 |
Biomarker
|
disease |
BEFREE |
Our study demonstrates a significant role for mRNA-edited Gabra3 in breast cancer metastasis.
|
26869349 |
2016 |
Lymphatic Metastasis
|
0.010 |
Biomarker
|
disease |
BEFREE |
GABRA3 promotes lymphatic metastasis in lung adenocarcinoma by mediating upregulation of matrix metalloproteinases.
|
27081042 |
2016 |
Adenocarcinoma of lung (disorder)
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
Herein, we show that high GABRA3 protein expression in lung adenocarcinoma correlated positively with disease stage, lymphatic metastasis status and poor patient survival.
|
27081042 |
2016 |
Secondary malignant neoplasm of lung
|
0.010 |
Biomarker
|
disease |
BEFREE |
GABRA3 promotes lymphatic metastasis in lung adenocarcinoma by mediating upregulation of matrix metalloproteinases.
|
27081042 |
2016 |
Breast Carcinoma
|
0.010 |
Biomarker
|
disease |
BEFREE |
Our study demonstrates a significant role for mRNA-edited Gabra3 in breast cancer metastasis.
|
26869349 |
2016 |
Secondary malignant neoplasm of lymph node
|
0.010 |
Biomarker
|
disease |
BEFREE |
These results indicate that GABRA3 promotes lymph node metastasis and may thus be an effective therapeutic target for anticancer treatment.
|
27081042 |
2016 |
Tumor Cell Invasion
|
0.010 |
AlteredExpression
|
phenotype |
BEFREE |
A-to-I-edited Gabra3 has reduced cell surface expression and suppresses the activation of AKT required for cell migration and invasion.
|
26869349 |
2016 |
Lung Neoplasms
|
0.010 |
AlteredExpression
|
group |
BEFREE |
Additionally, we show that high CT-GABRA3 transcription correlates with reduced TET1 mRNA levels in vivo in lung tumors.
|
25089631 |
2014 |
melanoma
|
0.010 |
Biomarker
|
disease |
BEFREE |
Here, we report identification of a novel cancer-germline transcript (CT-GABRA3) displaying DNA hypomethylation-dependent activation in various tumors, including melanoma and lung carcinoma.
|
25089631 |
2014 |
Neoplasms
|
0.010 |
Biomarker
|
group |
BEFREE |
CT-GABRA3 also carries a microRNA (miR-767) with predicted target sites in TET1 and TET3, two members of the ten-eleven-translocation family of tumor suppressor genes, which are involved in the conversion of 5-methylcytosines to 5-hydroxymethylcytosines (5hmC) in DNA.
|
25089631 |
2014 |
Hypokalemic periodic paralysis
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
Association of genetic variants in GABRA3 gene and thyrotoxic hypokalaemic periodic paralysis in Thai population.
|
17970773 |
2008 |
Liver carcinoma
|
0.010 |
Biomarker
|
disease |
BEFREE |
We determined the in vitro and in vivo effect of GABA in the proliferation of GABRA3-positive cell lines, and found that GABA increased HCC growth in a dose-dependent manner.
|
19084931 |
2008 |
Unipolar Depression
|
0.010 |
Biomarker
|
disease |
BEFREE |
The results of our study indicate that GABRA 3 gene might also be involved in the genetic pathophysiology of unipolar major depressive disorder (at least in female patients), even if the findings do not support a predominant role of GABRA 3.
|
15048654 |
2004 |
Major Depressive Disorder
|
0.010 |
Biomarker
|
disease |
BEFREE |
The results of our study indicate that GABRA 3 gene might also be involved in the genetic pathophysiology of unipolar major depressive disorder (at least in female patients), even if the findings do not support a predominant role of GABRA 3.
|
15048654 |
2004 |
Mood Disorders
|
0.010 |
Biomarker
|
group |
BEFREE |
Lack of association between GABRA3 and unipolar affective disorder: a multicentre study.
|
11602034 |
2001 |
nervous system disorder
|
0.010 |
Biomarker
|
group |
BEFREE |
The genomic characterization of GLUR3 and GABRA3 will allow mutational analysis of these genes as candidates for other X-linked neurological disorders mapping to Xq25-Xq26 and Xq28.
|
10602120 |
2000 |